Key Takeaways
- • German start-ups raised €3.4 billion in Q2 2026, marking the strongest quarter since Q2 2022 and a €1.8 billion increase from Q1 2026's €1.6 billion.
- • Seven mega-deals exceeding €100 million each drove the quarter, including one artificial intelligence transaction valued at over €1 billion.
- • Only 86 deals of €1 million or more closed in Q2, compared to a 2022 record of 626 annual transactions, indicating capital concentration among fewer start-ups despite increased founding activity.
- • Scale-up segment companies captured 72% of Q2 capital invested, with healthcare businesses representing one in four deals and demonstrating sustained investor demand.
- • Year-to-date 2026 transaction count stands at 184 deals (€1 million+), positioning toward approximately 370 annual deals if momentum continues—well below the 380 deals completed in 2025 and the 626-deal peak in 2022.
Summary
Germany's venture capital market demonstrated significant momentum in the second quarter of 2026, with start-ups securing €3.4 billion in funding—the strongest quarterly performance in four years. This represented a substantial €1.8 billion increase from the first quarter's €1.6 billion and marked a material rebound from the market's cautious posture evident in late 2025.
According to Dr. Dirk Schumacher, Chief Economist at KfW, the quarter's strength was heavily driven by mega-transactions, with seven deals exceeding €100 million each, including a notably prominent artificial intelligence transaction valued in excess of €1 billion. However, Schumacher cautioned that while the absolute volume remained robust, the composition of deals revealed underlying structural concerns: "Large deals dominate. Nevertheless, we must not lose sight of the fact that, with only 86 transactions of EUR 1 million or more, there is still room for improvement."
The concentration trend is pronounced when viewed against historical benchmarks. The year-to-date transaction count through Q2 stands at 184 deals of €1 million or greater, compared to 380 transactions completed across all of 2025 and a 2022 peak of 626 annual deals. While annual investment volumes have stabilized at approximately €7 billion from 2023 through 2025, these funds are being distributed among substantially fewer companies—a dynamic at odds with the expansion in overall start-up formation during the same period.
Scale-up segment companies—businesses beyond the initial start-up phase in strong growth mode—absorbed 72% of Q2 capital, underscoring how large funding rounds concentrated within fewer, more mature entities. The healthcare sector emerged as a particular investor focus, accounting for one in four deals completed during the quarter. This sectoral demand reflects broader investor appetite for defensive, cash-generative business models in the face of macroeconomic uncertainty.
The KfW findings suggest a bifurcated market: robust headline growth driven by selective mega-deals targeting proven scale-ups and healthcare innovation, contrasted with thinning deal flow across the broader start-up ecosystem. This capital concentration pattern, while producing strong quarterly volumes, raises questions about funding accessibility for early-stage ventures and diversification of the German venture landscape.
According to Dr. Dirk Schumacher, Chief Economist at KfW, the quarter's strength was heavily driven by mega-transactions, with seven deals exceeding €100 million each, including a notably prominent artificial intelligence transaction valued in excess of €1 billion. However, Schumacher cautioned that while the absolute volume remained robust, the composition of deals revealed underlying structural concerns: "Large deals dominate. Nevertheless, we must not lose sight of the fact that, with only 86 transactions of EUR 1 million or more, there is still room for improvement."
The concentration trend is pronounced when viewed against historical benchmarks. The year-to-date transaction count through Q2 stands at 184 deals of €1 million or greater, compared to 380 transactions completed across all of 2025 and a 2022 peak of 626 annual deals. While annual investment volumes have stabilized at approximately €7 billion from 2023 through 2025, these funds are being distributed among substantially fewer companies—a dynamic at odds with the expansion in overall start-up formation during the same period.
Scale-up segment companies—businesses beyond the initial start-up phase in strong growth mode—absorbed 72% of Q2 capital, underscoring how large funding rounds concentrated within fewer, more mature entities. The healthcare sector emerged as a particular investor focus, accounting for one in four deals completed during the quarter. This sectoral demand reflects broader investor appetite for defensive, cash-generative business models in the face of macroeconomic uncertainty.
The KfW findings suggest a bifurcated market: robust headline growth driven by selective mega-deals targeting proven scale-ups and healthcare innovation, contrasted with thinning deal flow across the broader start-up ecosystem. This capital concentration pattern, while producing strong quarterly volumes, raises questions about funding accessibility for early-stage ventures and diversification of the German venture landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.